Polyphyllin II regulates ROS levels and promotes ferroptosis in bladder cancer cells.

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Bladder cancer presents significant challenges due to high recurrence rates and limited therapeutic strategies.
• Ferroptosis, a regulated form of cell death dependent on iron, plays a critical role in cancer development and treatment response.

Purpose of the Study:

• To investigate the regulatory mechanisms of polyphyllin II (PPII) on ferroptosis in bladder cancer cells.
• To determine the effect of PPII on bladder cancer cell proliferation and identify associated molecular pathways.

Main Methods:

• Cell viability and colony formation assays were used to assess PPII's impact on proliferation.
• RNA sequencing and subsequent Gene Ontology/pathway enrichment analyses identified differentially expressed genes and affected pathways.
• Measurements of reactive oxygen species (ROS) levels, Fe²+ accumulation, and glutathione peroxidase 4 (GPX4) expression were performed.

Main Results:

• PPII significantly inhibited bladder cancer cell proliferation in a dose-dependent manner.
• RNA sequencing revealed that ferroptosis-related pathways were enriched following PPII treatment.
• PPII treatment led to increased ROS levels, enhanced Fe²+ accumulation, and decreased GPX4 expression in bladder cancer cells.

Conclusions:

• Polyphyllin II effectively promotes ferroptosis in bladder cancer cells.
• The mechanism involves modulating ROS levels and GPX4 activity, offering a potential therapeutic strategy.
• Further research is needed to explore PPII's molecular mechanisms and its potential in combination therapies for bladder cancer.